Abstract
This chapter discusses the genetics, metabolic actions, substrates, inducers, and inhibitors of cytochrome P450 3A4.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dresser GK, Spence JD, et al. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokinet. 2000;38(1):41–57.
Pal D, Mitra AK. MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci. 2006;78(18):2131–45.
Ohno Y, Hisaka A, et al. General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs. Clin Pharmacokinet. 2007;46(8):681–96.
Paine MF, Khalighi M, Fisher JM, et al. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Phamacol Exp Ther. 1997;283:1552–62.
Sandson NB. Drug-Drug Interaction Primer: A Compendium of Case Vignettes for the Practicing Clinician. Washington DC: American Psychiatric Publishing, Inc; 2007.
Ketter TA, Flockhart DA, Post RM, et al. The emerging role of cytochrome P4503A in psychopharmacology. J Clin Psychopharmacol. 1995;15:387–8.
Monahan BP, Ferguson CL, Killeavy ES, et al. Torsades de pointes occurring in association with terfenadine use. JAMA. 1990;264:2788–90.
Tsai WC, Tsai LM, Chen JH. Combined use of astemizole and ketoconazole resulting in Torsades de pointes. J Formos Med Assoc. 1997;96:144–6.
Ayanian JZ, Fuchs CS, Stone RM. Lovastatin and rhabdomyolysis (letter). Ann Intern Med. 1988;109:682–3.
Corpier CL, Jones PH, Suki WN, et al. Rhabdomyolysis and renal injury with lovastatin use: report of two cases in cardiac transplant recipients. JAMA. 1988;260:239–41.
Biesenbach G, Janko O, Stuby U, et al. Myoglobinuric renal failure due to long-standing lovastatin therapy in a patient with pre-existing chronic renal insufficiency. Nephrol Dial Transplant. 1996;11:2059–60.
Hino I, Akama H, Furuya T, et al. Pravastatin-induced rhabdomyolysis in a patient with mixed connective tissue disease. Arthritis Rheum. 1996;39:1259–60.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
DeCou, J., Birgenheier, N., Dull, R.O. (2015). CYP3A4: The Workhorse. In: Marcucci, C., et al. A Case Approach to Perioperative Drug-Drug Interactions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7495-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7495-1_7
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7494-4
Online ISBN: 978-1-4614-7495-1
eBook Packages: MedicineMedicine (R0)